Recent U.S. Food and Drug Administration advisory committee strain recommendations could make this season’s influenza (flu) vaccine more effective than ever. But, will an epidemic of public apathy undermine immunization efforts?
The efficacy of influenza (flu) vaccines has been greatly improved over the past several decades, but the flu virus still severely sickens hundreds of thousands of individuals each year. Is it possible that scientists have discovered a way to change that?
Hard-to-treat bacterial skin infections are becoming more common. A better understanding of them is the first step toward improving treatment.
Polio still plagues a few parts of the world, and some of its past victims are vulnerable to a recurrence but in a less serious form.
The plasma donor is the first vital part of the process to produce safe and effective plasma protein therapeutics, and the industry prioritizes the safety and health of its plasma donors.
A physician diagnoses the condition and either treats it or refers the patient to someone else for treatment. End of story. Or is that just the beginning of the story? Narrative medicine challenges the medical model by bringing a new tool to the table: the story of the patient.
Screening and new treatments offer a high cure rate for those affected by hepatitis C, which was once a grave disease.
Although noncommunicable diseases are the leading cause of morbidity and mortality in most developed nations, zoonotic diseases remain a major public health concern.
An ongoing revolution in healthcare ties data and reimbursement with the demand for analytics that provide insight into a variety of areas.
Changes are needed in the way scientific research is currently conducted to ensure its legitimacy and efficacy.
